Quick Answer
Apyx Medical Corp reported Operating Income Loss of -$6.45 million for the year ending 2025.
- Apyx Medical Corp showed an increase of +65.8% in Operating Income Loss from 2024 to 2025.
- This data is from Apyx Medical Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Apyx Medical Corp's Operating Income Loss has declined by 1,001.5%.
- Historical annual values: Fiscal year 2025: -$6.45 million | Fiscal year 2024: -$18.85 million | Fiscal year 2023: -$17.26 million | Fiscal year 2022: -$23.56 million | Fiscal year 2021: -$14.45 million | Fiscal year 2020: -$20.08 million | Fiscal year 2019: -$20.87 million | Fiscal year 2018: -$14.28 million | Fiscal year 2017: -$13.89 million | Fiscal year 2016: -$11.39 million | Fiscal year 2015: -$6.99 million | Fiscal year 2014: -$5.85 million | Fiscal year 2013: -$3.67 million | Fiscal year 2012: $1.05 million | Fiscal year 2011: -$18.0 thousand | Fiscal year 2010: -$2.75 million | Fiscal year 2009: $715.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: